Diabetes complications

Prognostic impact of switching to the 2021 chronic kidney disease epidemiology collaboration creatinine-based equation in Caucasian patients with type 2 diabetes: the Renal Insufficiency and Cardiovascular events (RIACE) Italian Multicenter Study

Cardiovasc DiabetolPublished Prospective cohort study

Study context

Population
Caucasian patients with T2D, 19 Italian centres, enrolled 2006–2008vital status for 15,656
Participants
15,773 patients
Exposure
2021 vs 2009 CKD-EPI creatinine-based equation
Outcome
eGFR with 2021 vs 2009 CKD-EPI equation
Follow-up
Baseline
Methodological detailsmulticentre
  • Multicentre

Main finding

As reported in the abstract

Estimated glomerular filtration rate (eGFR) increased in all patients with the 2021 equation, except those with a 2009 eGFR ≥105

293 individuals

Reduced eGFR, 2009 to 2021 equation (reclassification)

17.28 to 13.96%

Any Chronic Kidney Disease (CKD), 2009 to 2021 equation (reclassification)

36.23 to 34.03%

Observational data: associations, not effects.

Further findings

Risk of death (vs 2009 G1) in reclassified vs non-reclassified · to 31 October 2015

Lower risk of death for reclassified than non-reclassified in all eGFR categories; significant only in G4-G5
ROC curves statistically, but not clinically different with the two equations

Profile of reclassified individuals · baseline

Reclassified had better cardiometabolic risk profile, lower prevalence of complications and medication use

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Prognostic impact of switching to the 2021 chronic kidney disease epidemiology collaboration creatinine-based equation in Caucasian patients with type 2 diabetes: the Renal Insufficiency and Cardiovascular events (RIACE) Italian Multicenter Study. Cardiovasc Diabetol. Published 24 October 2024. doi:10.1186/s12933-024-02450-5

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.